Apply User Fees To Postmarket Data Collection In MDUFA IV, Pew Argues

In the next round of MDUFA talks, FDA should target some industry user fees at gathering postmarket data, to support FDA’s growing emphasis on relying on postmarket data to resolve premarket uncertainties, Pew says in Aug. 12 comments.

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation